Market Research Future
Animal Vaccines Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Animal Vaccines Market - Overview The Global Animal Vaccines Market is expected to grow at an approximate CAGR of 5.65% during forecast period, 2018–2023. Increasing participation of market players is the key factor driving the animal vaccines market. For instance, in 2015, Boehringer Ingelheim launched two new swine vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) i.e. Ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for breeding gilts. Various other factors such as increasing incidence of livestock diseases, technological advancements, increasing adoption of companion animals, and rising government initiatives are also expected to propel the growth of the market. However, high storage costs for vaccines, and inadequate surveillance and reporting systems can hinder the market growth over the forecast period. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/7184 Players Covered: Some of the key players in the global animal vaccines market are Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, China Animal Husbandry, Elanco Animal Health, Hester, Idt Biologika, Indian Immunologicals Limited, Merck Animal Health, MSD Animal Health, Phibro Animal Health, Tianjin Ringpu, Vetoquinol, Zoetis Inc., and others. Animal Vaccines Market – Segments The Global Animal Vaccines Market is segmented based on type, technology, indications, composition and region. The Global Animal Vaccines Market, by type is segmented into static porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others. The livestock vaccine is further segmented into bovine vaccines, and small ruminant vaccines. The livestock vaccine is further segmented into canine vaccines, and feline vaccines. The market, by technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others. Based on indications, the market is segmented into foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome, and others. Based on composition, the market is segmented into mono vaccine, and combination vaccines.